What is hairy cell leukemia?

What is a decentralized clinical trial? Why are clincal trials being decentralized?
How is patient safety protected in clinical trials?
What is the risk of infection associated with BCMA directed therapies?
Efficacy of Navitoclax and Ruxolitinib | Naveen Pemmaraju, MD | EHA 2024
Discussing the Unmet Clinical Needs in 2 Special CLL Patient Groups | Silvia Deaglio, MD | EHA 2024